{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:17:43Z","timestamp":1790072263334,"version":"4.0.1"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["2023AH053300"],"award-info":[{"award-number":["2023AH053300"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["YJS20250024"],"award-info":[{"award-number":["YJS20250024"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioactmat.2026.03.056","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:49:20Z","timestamp":1775022560000},"page":"1-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery"],"prefix":"10.1016","volume":"63","author":[{"given":"Yayun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weinan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6347-8582","authenticated-orcid":false,"given":"Yechun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyou","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4903-3447","authenticated-orcid":false,"given":"Haisheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2026.03.056_bib1","series-title":"World Health Statistics 2024: Monitoring Health for the Sdgs, Sustainable Development Goals","year":"2024"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12879-024-09268-2","article-title":"Relapsing bronchopneumonia due to community-associated methicillin-resistant Staphylococcus aureus: a case report","volume":"24","author":"Shimada","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib3","first-page":"20","article-title":"Navigating antibiotic use within the lower respiratory tract infection spectrum","volume":"113","author":"Dangor","year":"2023","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib4","article-title":"Co-existence and co-infection of influenza A viruses and coronaviruses: public health challenges","volume":"3","author":"Yang","year":"2022","journal-title":"Innovation"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04445-2020","article-title":"Prognostic factors of severe community-acquired staphylococcal pneumonia in France","volume":"58","author":"Gillet","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.27266","article-title":"Recurrent pulmonary tuberculosis in China, 2005 to 2021","volume":"7","author":"Li","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(24)00011-2","article-title":"Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis","volume":"24","author":"Stuck","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40779-020-00289-x","article-title":"Outbreak of Mycoplasma pneumoniae at a military academy","volume":"7","author":"Zhang","year":"2020","journal-title":"Milit. Med. Res."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib9","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jointm.2024.07.006","article-title":"Nebulized aminoglycosides for ventilator-associated pneumonia: methodological considerations and lessons from experimental studies","volume":"5","author":"Rouby","year":"2024","journal-title":"J. Intensive Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jinf.2021.05.010","article-title":"Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: a systematic review","volume":"83","author":"Dillard","year":"2021","journal-title":"J. Infect."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41385-020-00370-7","article-title":"Cellular and functional heterogeneity of the airway epithelium","volume":"14","author":"Davis","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107661","article-title":"Inhaled antibiotics: a promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens","volume":"227","author":"Islam","year":"2024","journal-title":"Respir. Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2020.07.002","article-title":"Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases","volume":"325","author":"Douafer","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jointm.2022.04.003","article-title":"Aerosol therapy during mechanical ventilation in intensive care units: a questionnaire-based survey of 2203 ICU medical staff in China","volume":"2","author":"Sun","year":"2022","journal-title":"J. Intensive Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00281-024-01003-y","article-title":"Physiological and immunological barriers in the lung","volume":"45","author":"Kageyama","year":"2024","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101942","article-title":"Inhaled drug delivery: past, present, and future","volume":"52","author":"Yue","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.2019.21118","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia","volume":"323","author":"Olson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib19","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/crj.12674","article-title":"Diagnosis and treatment of community\u2010acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese thoracic society, Chinese medical association","volume":"12","author":"Cao","year":"2017","journal-title":"Clin. Res. J."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"49","author":"Martin-Loeches","year":"2023","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01451-2020","article-title":"Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study","volume":"57","author":"Loebinger","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/17476348.2021.1875821","article-title":"Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection","volume":"15","author":"Zhang","year":"2021","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chest.2024.01.045","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: updated systematic review and meta-analysis","volume":"166","author":"Cordeiro","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12890-024-03032-7","article-title":"Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis","volume":"24","author":"Buend\u00eda","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib25","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1056\/NEJMoa2310307","article-title":"Inhaled amikacin to prevent ventilator-associated pneumonia","volume":"389","author":"Ehrmann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib26","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib27","series-title":"Statpearls. Treasure Island (FL)","article-title":"Anatomy, head and neck, trachea","author":"Mieczkowski","year":"2023"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00101-017-0355-8","article-title":"Atemwegsanatomie: die notfallmedizinisch relevanten Strukturen [Airway anatomy: relevant structures in emergency medicine]","volume":"66","author":"Schulze","year":"2017","journal-title":"Anaesthesist"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib29","series-title":"Statpearls. Treasure Island (FL)","article-title":"Histology, lung","author":"Khan","year":"2025"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib30","series-title":"Statpearls. Treasure Island (FL)","article-title":"Anatomy, airway","author":"Ball","year":"2023"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122661","article-title":"Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers","volume":"634","author":"Pangeni","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/ismejo\/wrae036","article-title":"In vivo evolution of antimicrobial resistance in a biofilm model of Pseudomonas aeruginosa lung infection","volume":"18","author":"Higazy","year":"2024","journal-title":"ISME J."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.nano.2015.01.007","article-title":"Inhalable nanoparticulate powders for respiratory delivery","volume":"11","author":"Muralidharan","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib34","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1007\/s00210-025-04305-6","article-title":"Advancing pulmonary therapy: the role of dry powder inhalation technology in lung disease management","volume":"398","author":"Ahmad","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib35","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s13346-023-01346-3","article-title":"Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin","volume":"13","author":"Bianchera","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120768","article-title":"Pulmonary biofilm-based chronic infections and inhaled treatment strategies","volume":"604","author":"Ding","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.addr.2020.05.003","article-title":"Post-inhalation cough with therapeutic aerosols: formulation considerations","volume":"165\u2013166","author":"Sahakijpijarn","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/17425247.2023.2263360","article-title":"Multifunctional systems based on nano-in-microparticles as strategies for drug delivery: advances, challenges, and future perspectives","volume":"20","author":"Carvalho","year":"2023","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106546","article-title":"Population pharmacokinetic modeling of the influence of chronic and acute biofilm-forming Pseudomonas aeruginosa lung infection on ciprofloxacin free pulmonary and epithelial lining fluid concentrations","volume":"189","author":"Lock","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.969326","article-title":"Biofilm aggregates and the host airway-microbial interface","volume":"12","author":"Hall-Stoodley","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114173","article-title":"Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?","volume":"183","author":"Forest","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib42","first-page":"55","article-title":"Macrophage based drug delivery: key challenges and strategies","volume":"38","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib43","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1111\/bph.15197","article-title":"Cough as an adverse effect on inhalation pharmaceutical products","volume":"177","author":"Chang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib44","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/jac\/dkac240","article-title":"Understanding the suitability of established antibiotics for oral inhalation from a pharmacokinetic perspective: an integrated model-based investigation based on rifampicin, ciprofloxacin and tigecycline in vivo data","volume":"77","author":"Himstedt","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biomaterials.2018.01.022","article-title":"Azithromycin-loaded respirable microparticles for targeted pulmonary delivery for the treatment of pneumonia","volume":"160","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib46","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.scib.2023.11.004","article-title":"Polymyxin B sulfate inhalable microparticles with high-lectin-affinity sugar carriers for efficient treatment of biofilm-associated pulmonary infections","volume":"68","author":"Zhou","year":"2023","journal-title":"Sci. Bull."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123949","article-title":"Co-spray dried inhalable composite powders of ciprofloxacin and alginate oligosaccharide as anti-biofilm therapy","volume":"654","author":"Zhang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40199-021-00426-4","article-title":"Spray freeze drying to solidify Nanosuspension of Cefixime into inhalable microparticles","volume":"30","author":"Haghighi","year":"2022","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102306","article-title":"Spray dried tigecycline dry powder aerosols for the treatment of nontuberculous mycobacterial pulmonary infections","volume":"139","author":"Maloney","year":"2023","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213594","article-title":"Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation","volume":"154","author":"Jadhav","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124309","article-title":"Inhalable solid lipid nanoparticles of levofloxacin for potential tuberculosis treatment","volume":"660","author":"Paul","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123841","article-title":"Inhaled dry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection","volume":"653","author":"Dallal Bashi","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib53","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/10837450.2024.2427186","article-title":"Spray dried polymyxin B liposome for inhalation against gram-negative bacteria","volume":"29","author":"Gugu","year":"2024","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2024.214027","article-title":"Continuously producible aztreonam-loaded inhalable lipid nanoparticles for cystic fibrosis-associated Pseudomonas aeruginosa infections\u2013Development and in-vitro characterization","volume":"166","author":"Chauhan","year":"2025","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/03639045.2022.2135101","article-title":"A facile one-step jet-milling approach for the preparation of proliposomal dry powder for inhalation as effective delivery system for anti-TB therapeutics","volume":"48","author":"Srichana","year":"2022","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00517-20","article-title":"Therapeutic efficacy of novel antimicrobial peptide AA139-nanomedicines in a multidrug-resistant Klebsiella pneumoniae pneumonia-septicemia model in rats","volume":"64","author":"van der Weide","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib57","article-title":"Infection\u2010responsive polysaccharide\u2010based drug\u2010loaded nano\u2010assembly for dual\u2010modal treatment against drug\u2010resistant bacterial lung infection","volume":"2","author":"Han","year":"2024","journal-title":"BMEMat"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202300580","article-title":"ROS\u2010responsive poly (\u03b1\u2010l\u2010lysine)\u2010based nanoparticles loaded with doxycycline combat oxidative stress and bacterial infection","volume":"24","author":"Wang","year":"2024","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114088","article-title":"Dual tobramycin and docosahexaenoic acid loaded nanoemulsions combating Pseudomonas aeruginosa-induced pulmonary infection","volume":"242","author":"Sun","year":"2024","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118543","article-title":"Dry powder formulation for pulmonary infections: ciprofloxacin loaded in chitosan sub-micron particles generated by electrospray","volume":"273","author":"Arauzo","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade8039","article-title":"Codelivery of synergistic antimicrobials with polyelectrolyte nanocomplexes to treat bacterial biofilms and lung infections","volume":"9","author":"Finbloom","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib62","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jconrel.2024.09.036","article-title":"An inhalable nanoparticle enabling virulence factor elimination and antibiotics delivery for pneumococcal pneumonia therapy","volume":"375","author":"Dong","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib63","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1021\/acs.molpharmaceut.0c00390","article-title":"Inhalable nanocomposite microparticles with enhanced dissolution and superior aerosol performance","volume":"17","author":"Zhu","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado1749","article-title":"Inhalable SPRAY nanoparticles by modular peptide assemblies reverse alveolar inflammation in lethal Gram-negative bacteria infection","volume":"10","author":"Chen","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202302551","article-title":"Inhalable capsular polysaccharide\u2010camouflaged gallium\u2010polyphenol nanoparticles enhance lung cancer chemotherapy by depleting local lung microbiota","volume":"35","author":"Han","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd7904","article-title":"Inhaled immunoantimicrobials for the treatment of chronic obstructive pulmonary disease","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/jamp.2022.0002","article-title":"Inhalation potential of rifampicin-loaded novel metal\u2013organic frameworks for improved lung delivery: physicochemical characterization, in vitro aerosolization and antimycobacterial studies","volume":"35","author":"Kujur","year":"2022","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib68","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41563-022-01360-9","article-title":"Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia","volume":"21","author":"Zhang","year":"2022","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib69","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/pharmaceutics17030347","article-title":"Tolerability and pharmacokinetic evaluation of inhaled dry powder tobramycin in children with cystic fibrosis","volume":"17","author":"Akkerman-Nijland","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib70","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S2213-2600(24)00225-X","article-title":"Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months","volume":"12","author":"Haworth","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib71","article-title":"Macrolide antibiotics (including azithromycin) for cystic fibrosis","volume":"2","author":"Southern","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib72","doi-asserted-by":"crossref","first-page":"448.e1","DOI":"10.1016\/j.cmi.2021.07.015","article-title":"Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics","volume":"28","author":"Ruth","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119575","article-title":"Fumaryl diketopiperazine based effervescent microparticles to escape macrophage phagocytosis for enhanced treatment of pneumonia via pulmonary delivery","volume":"228","author":"Wang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib74","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s40265-024-02102-8","article-title":"The challenge of treating infections caused by metallo\u2010\u03b2\u2010lactamase\u2013producing gram-negative bacteria: a narrative review","volume":"84","author":"Hidalgo-Tenorio","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib76","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1186\/s12879-024-09759-2","article-title":"Polymyxin B vs. colistin: the comparison of neurotoxic and nephrotoxic effects of the two polymyxins","volume":"24","author":"Aysert-Yildiz","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib77","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-021-21748-6","article-title":"Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib78","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.actbio.2024.06.026","article-title":"Precise antibiotic delivery to the lung infection microenvironment boosts the treatment of pneumonia with decreased gut dysbiosis","volume":"184","author":"Fu","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib79","article-title":"Bio\u2010responsive sliver peroxide\u2010nanocarrier serves as broad\u2010spectrum metallo\u2010\u03b2\u2010lactamase inhibitor for combating severe pneumonia","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib80","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2019.10.038","article-title":"Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis","volume":"314","author":"Lababidi","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib81","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11095-020-02889-7","article-title":"Advancement of a positive-pressure dry powder inhaler for children: use of a vertical aerosolization chamber and three-dimensional rod array interface","volume":"37","author":"Farkas","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124504","article-title":"Inhalable tobramycin EEG powder formulation for treating Pseudomonas aeruginosa-induced lung infection","volume":"662","author":"Pangeni","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib83","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s11095-022-03344-5","article-title":"Improved aerosolization stability of inhalable tobramycin powder formulation by co-spray drying with colistin","volume":"39","author":"Pathak","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib84","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0021","article-title":"Assessment of the frequency of dual allergy to penicillins and cefazolin: a systematic review and meta-analysis","volume":"156","author":"Sousa-Pinto","year":"2021","journal-title":"JAMA Surg."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121013","article-title":"Aerosol inhalation delivery of cefazolin in mice: pharmacokinetic measurements and antibacterial effect","volume":"607","author":"Valiulin","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib86","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib87","article-title":"Quantum chemical prediction of effects of temperature on hydrolysis rate of penicillin under weakly acidic condition","volume":"806","author":"Zhang","year":"2022","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119684","article-title":"Development and characterization of meropenem dry powder inhaler formulation for pulmonary drug delivery","volume":"587","author":"Muneer","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib89","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw6693","article-title":"Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo","volume":"4","author":"Rothchild","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib90","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230859","article-title":"A half-century of research on tuberculosis: successes and challenges","volume":"220","author":"Bloom","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124755","article-title":"An aerosol nanocomposite microparticle formulation using rifampicin-cyclodextrin inclusion complexes for the treatment of pulmonary diseases","volume":"665","author":"Freeman","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/cnma.202400296","article-title":"Rifampicin\u2010loaded nano\u2010in\u2010microparticles (Trojan particles) as a pulmonary delivery system for tuberculosis treatment","volume":"10","author":"Pham","year":"2024","journal-title":"ChemNanoMat"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib93","article-title":"Rifabutin loaded inhalable \u03b2-glucan microparticle based drug delivery system for pulmonary TB","volume":"14","author":"Ahmad","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123984","article-title":"Triple combination dry powder formulation of pretomanid, moxifloxacin, and pyrazinamide for treatment of multidrug-resistant tuberculosis","volume":"654","author":"Fan","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib95","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/10837450.2022.2084554","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration","volume":"27","author":"Akbari","year":"2022","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202102117","article-title":"Nano\u2010in\u2010microparticles for aerosol delivery of antibiotic\u2010loaded, fucose\u2010derivatized, and macrophage\u2010targeted liposomes to combat mycobacterial infections: in vitro deposition, pulmonary barrier interactions, and targeted delivery","volume":"11","author":"Huck","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib97","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1186\/s12967-024-05711-9","article-title":"Innovative nebulization delivery of lipid nanoparticle-encapsulated siRNA: a therapeutic advance for Staphylococcus aureus-induced pneumonia","volume":"22","author":"Meng","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib98","first-page":"406","article-title":"Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization","volume":"43","author":"Liao","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib99","doi-asserted-by":"crossref","first-page":"14957","DOI":"10.1002\/anie.202004994","article-title":"Protein and mRNA delivery enabled by cholesteryl\u2010based biodegradable lipidoid nanoparticles","volume":"59","author":"Li","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib100","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","article-title":"Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib101","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12890-024-03261-w","article-title":"Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation","volume":"24","author":"Urabe","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib102","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2147\/IJN.S286896","article-title":"Development of inhalable nanostructured lipid carriers for ciprofloxacin for noncystic fibrosis bronchiectasis treatment","volume":"16","author":"Almurshedi","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124208","article-title":"Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication","volume":"658","author":"Wang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk9754","article-title":"Biofunctional lipid nanoparticles for precision treatment and prophylaxis of bacterial infections","volume":"10","author":"Peng","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202100531","article-title":"Tobramycin liquid crystal nanoparticles eradicate cystic fibrosis\u2010related Pseudomonas aeruginosa biofilms","volume":"17","author":"Thorn","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib106","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jcf.2020.01.009","article-title":"In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments","volume":"19","author":"Christophersen","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib107","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1093\/jac\/dkac187","article-title":"Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin","volume":"77","author":"Lipp","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib108","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s40265-020-01359-z","article-title":"Inhaled liposomal antimicrobial delivery in lung infections","volume":"80","author":"Bassetti","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124608","article-title":"Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosis","volume":"664","author":"Aekwattanaphol","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123201","article-title":"Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung","volume":"642","author":"Corzo","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106774","article-title":"Mechanisms of action of berberine hydrochloride in planktonic cells and biofilms of Pseudomonas aeruginosa","volume":"193","author":"Liu","year":"2024","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib112","article-title":"Cholesterol microdomain enhances the biofilm eradication of antibiotic liposomes","volume":"11","author":"Xie","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib113","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/jamp.2021.0049","article-title":"Resveratrol-loaded dipalmitoylphosphatidylcholine liposomal large porous microparticle inhalations for the treatment of bacterial pneumonia caused by Acinetobacter baumannii","volume":"36","author":"Yu","year":"2023","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib114","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.2147\/IJN.S445955","article-title":"Enzyme-linked lipid nanocarriers for coping pseudomonal pulmonary infection. Would nanocarriers complement biofilm disruption or pave its road?","volume":"19","author":"Nafee","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib115","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib116","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn7162","article-title":"Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge","volume":"8","author":"Bai","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib117","article-title":"Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium","volume":"31","author":"Patel","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901542","article-title":"Polymyxin B\u2010polysaccharide polyion nanocomplex with improved biocompatibility and unaffected antibacterial activity for acute lung infection management","volume":"9","author":"Chai","year":"2020","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib119","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1039\/D3TB02970K","article-title":"Inhalable mucin-permeable nanomicelles deliver antibiotics for effective treatment of chronic pneumonia","volume":"12","author":"Jiang","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib120","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1039\/D4TB01224K","article-title":"Size-tailored and acid-degradable polyvinyl alcohol microgels for inhalation therapy of bacterial pneumonia","volume":"12","author":"Zhou","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202570044","article-title":"Multifaceted immunomodulatory nanocomplexes target neutrophilic\u2010ROS inflammation in acute lung injury","volume":"12","author":"Su","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib122","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1021\/acsami.9b19644","article-title":"Ultrasmall TPGS\u2013PLGA hybrid nanoparticles for site-specific delivery of antibiotics into Pseudomonas aeruginosa biofilms in lungs","volume":"12","author":"Wan","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120731","article-title":"Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs","volume":"604","author":"Guerreiro","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.123398","article-title":"Recent advances in cellulose-based antimicrobial films: a review","volume":"356","author":"Liu","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib125","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41563-024-02041-5","article-title":"Inhalable nanocatalytic therapeutics for viral pneumonia","volume":"24","author":"Peng","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib126","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1016\/j.matt.2021.07.001","article-title":"Material-herbology: an effective and safe strategy to eradicate lethal viral-bacterial pneumonia","volume":"4","author":"Li","year":"2021","journal-title":"Matter"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib127","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.fmre.2021.11.019","article-title":"Using tea nanoclusters as \u03b2-lactamase inhibitors to cure multidrug-resistant bacterial pneumonia: a promising therapeutic strategy by Chinese materioherbology","volume":"2","author":"Zhou","year":"2021","journal-title":"Fundam. Res."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib128","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41467-022-30125-w","article-title":"Microwave assisted antibacterial action of Garcinia nanoparticles on Gram-negative bacteria","volume":"13","author":"Qiao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib129","article-title":"Inhaled ciprofloxacin-loaded poly (2-ethyl-2-oxazoline) nanoparticles from dry powder inhaler formulation for the potential treatment of lower respiratory tract infections","volume":"16","author":"Kunda","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138233","article-title":"Muco-adhesive chitosan-coated polyphenol nanoparticle for treatment of infectious acute pneumonia through sustained pulmonary delivery of polymyxin B","volume":"284","author":"Fang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib131","article-title":"Ultrasmall cortex moutan nanoclusters for the therapy of pneumonia and colitis","volume":"12","author":"Li","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib132","doi-asserted-by":"crossref","first-page":"96","DOI":"10.34133\/research.0096","article-title":"Inflammation and microbiota regulation potentiate pneumonia therapy by biomimetic bacteria and macrophage membrane nanosystem","volume":"6","author":"Li","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132526","article-title":"Chitosan\/bovine serum albumin layer-by-layer assembled particles for non-invasive inhaled drug delivery to the lungs","volume":"271","author":"Chauhan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib134","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejpb.2021.07.017","article-title":"Porous particles and novel carrier particles with enhanced penetration for efficient pulmonary delivery of antitubercular drugs","volume":"167","author":"Tse","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejpb.2021.04.001","article-title":"Cytocompatibility and cellular interactions of chondroitin sulfate microparticles designed for inhaled tuberculosis treatment","volume":"163","author":"Rodrigues","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib136","article-title":"Interlayer electrons polarization of asymmetric metal Nanoclusters\/g-C3N4 for enhanced microwave therapy of pneumonia","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib137","article-title":"Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles","volume":"27","author":"Madrid Sani","year":"2024","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib138","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1248\/bpb.b22-00592","article-title":"Arbekacin-loaded inhalable nanocomposite particles specific to Pseudomonas aeruginosa prepared using a two-solution mixing-type spray nozzle","volume":"46","author":"Yamamoto","year":"2023","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121160","article-title":"Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa","volume":"610","author":"Yu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib140","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acsnano.3c01664","article-title":"Amorphous drug nanoparticles for inhalation therapy of multidrug-resistant tuberculosis","volume":"17","author":"Rudolph","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib141","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2020.10.010","article-title":"Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles","volume":"157","author":"Lababidi","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib142","first-page":"262","article-title":"Alveolar macrophage phagocytosis-evading inhaled microgels incorporating nintedanib-PLGA nanoparticles and pirfenidone-liposomes for improved treatment of pulmonary fibrosis","volume":"33","author":"Lee","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib143","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcis.2020.12.001","article-title":"Design of polymeric core-shell carriers for combination therapies","volume":"587","author":"Silva","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib144","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2024.06.022","article-title":"Targeted treatment for biofilm-based infections using PEGylated tobramycin","volume":"372","author":"Ding","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/jamp.2022.0078","article-title":"Aerosolizable pyrazinamide-loaded biodegradable nanoparticles for the management of pulmonary tuberculosis","volume":"37","author":"Parmar","year":"2024","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib146","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1208\/s12249-023-02585-w","article-title":"Inhaled adjunct therapy with second-line drug candidates for dose reduction in chemotherapeutic regimens for multi-drug-resistant tuberculosis","volume":"24","author":"Verma","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib147","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1007\/s13346-024-01571-4","article-title":"Poly (malic acid)-budesonide nanoconjugates embedded in microparticles for lung administration","volume":"14","author":"Tessier","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib148","doi-asserted-by":"crossref","first-page":"8666","DOI":"10.1039\/D3TB01550E","article-title":"Wet-adhesive \u03b3-PGA\/\u03b5-PLL hydrogel loaded with EGF for tracheal epithelial injury repair","volume":"11","author":"Hu","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib149","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1021\/acs.nanolett.4c02318","article-title":"Inhalable polymeric microparticles for phage and photothermal synergistic therapy of methicillin-resistant Staphylococcus aureus pneumonia","volume":"24","author":"Liu","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib150","article-title":"Advances in engineered phages for disease treatment","author":"Hou","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib151","doi-asserted-by":"crossref","DOI":"10.1172\/JCI187996","article-title":"Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches","volume":"135","author":"Kim","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199442","article-title":"Safety and tolerability of bronchoscopic and nebulised administration of bacteriophage","volume":"348","author":"Singh","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122679","article-title":"Bacteriophage endolysin powders for inhaled delivery against pulmonary infections","volume":"635","author":"Wang","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib154","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/infdis\/jiab112","article-title":"Benefits of aerosolized phages for the treatment of pneumonia due to methicillin-resistant Staphylococcus aureus: an experimental study in rats","volume":"225","author":"Prazak","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejpb.2020.11.019","article-title":"Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation\u2014A proof-of-principle study in a P. aeruginosa lung infection model","volume":"158","author":"Lin","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119952","article-title":"Storage stability of phage-ciprofloxacin combination powders against Pseudomonas aeruginosa respiratory infections","volume":"591","author":"Lin","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib157","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41551-018-0263-5","article-title":"Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections","volume":"2","author":"Agarwal","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib158","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2147\/IJN.S218966","article-title":"Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections","volume":"15","author":"Falciani","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib159","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay6817","article-title":"Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria","volume":"6","author":"Di","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123960","article-title":"Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis","volume":"654","author":"Shao","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib161","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40199-023-00460-4","article-title":"Novel therapeutic approach for the treatment of cystic fibrosis based on freeze-dried tridrug microparticles to treat cystic fibrosis","volume":"31","author":"Kabra","year":"2023","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib162","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jconrel.2020.08.022","article-title":"In vitro and in vivo antitubercular activity of benzothiazinone-loaded human serum albumin nanocarriers designed for inhalation","volume":"328","author":"Patel","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib163","article-title":"A multifunctional ionic liquid coating on 3D-Printed prostheses: combating infection, promoting osseointegration","volume":"31","author":"Li","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106442","article-title":"A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery","volume":"185","author":"Robla","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120974","article-title":"The rough inhalable ciprofloxacin hydrochloride microparticles based on silk fibroin for non-cystic fibrosis bronchiectasis therapy with good biocompatibility","volume":"607","author":"Lin","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib166","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00866-24","article-title":"Targeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia","volume":"68","author":"Baldry","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111095","article-title":"Ternary nanoparticle complex of antibiotic, polyelectrolyte, and mucolytic enzyme as a potential antibiotic delivery system in bronchiectasis therapy","volume":"193","author":"Tran","year":"2020","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib168","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202405103","article-title":"Research progress on antibacterial applications of bioactive materials in wound infections: design, challenges, and prospects","volume":"14","author":"Zheng","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib169","article-title":"Implanted microneedles loaded with sparfloxacin and zinc\u2010manganese sulfide nanoparticles activates immunity for postoperative triple\u2010negative breast cancer to prevent recurrence and metastasis","author":"Chu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113734","article-title":"Aptes-mediated Cu2(OH)3(NO3) nanomaterials on the surface of silicone catheters for abscess","volume":"234","author":"Wu","year":"2024","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib171","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.1038\/s41598-018-24200-w","article-title":"A novel in vitro metric predicts in vivo efficacy of inhaled silver-based antimicrobials in a murine Pseudomonas aeruginosa pneumonia model","volume":"8","author":"Shah","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121318","article-title":"Respirable spray dried vancomycin coated magnetic nanoparticles for localized lung delivery","volume":"611","author":"Abdelaziz","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib173","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/10717544.2019.1676841","article-title":"Active pulmonary targeting against tuberculosis (TB) via triple-encapsulation of Q203, bedaquiline and superparamagnetic iron oxides (SPIOs) in nanoparticle aggregates","volume":"26","author":"Poh","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib174","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800124","article-title":"Development of inhalable superparamagnetic iron oxide nanoparticles (SPIONs) in microparticulate system for antituberculosis drug delivery","volume":"7","author":"Miranda","year":"2018","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib175","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/antibiotics13070630","article-title":"In vitro evaluation of colistin conjugated with chitosan-capped gold nanoparticles as a possible formulation applied in a metered-dose inhaler","volume":"13","author":"Changsan","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib176","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2024.03.013","article-title":"Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis","volume":"369","author":"Campos Pacheco","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib177","doi-asserted-by":"crossref","first-page":"31923","DOI":"10.1021\/acsnano.4c09695","article-title":"A mucous permeable local delivery strategy based on manganese-enhanced bacterial cuproptosis-like death for bacterial pneumonia treatment","volume":"18","author":"Hua","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib178","first-page":"1","article-title":"An inhalable gallium-polyphenol nanoparticle blocks bacterial electron transport chain and signal transduction for anti-biofilm therapy","volume":"57","author":"Ni","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902650","article-title":"Engineering of nebulized metal\u2013phenolic capsules for controlled pulmonary deposition","volume":"7","author":"Ju","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1208\/s12249-024-02839-1","article-title":"Enhanced stability and solidification of volatile eugenol by cyclodextrin-metal organic framework for nasal powder delivery","volume":"25","author":"Zhu","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib181","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.3390\/molecules26216408","article-title":"Microencapsulated isoniazid-loaded metal\u2013organic frameworks for pulmonary administration of antituberculosis drugs","volume":"26","author":"Fern\u00e1ndez-Paz","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib182","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/pharmaceutics11120687","article-title":"An inhalable theranostic system for local tuberculosis treatment containing an isoniazid loaded metal organic framework Fe-MIL-101-NH2-from raw MOF to drug delivery system","volume":"11","author":"Wyszogrodzka-Gawe\u0142","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121768","article-title":"Concurrent antibiosis and anti-inflammation against bacterial pneumonia by zinc hexacyanoferrate nanocatalysts","volume":"289","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib184","article-title":"Atomized neutrophil membrane-coated MOF nanoparticles for direct delivery of dexamethasone for severe pneumonia","volume":"30","author":"Wang","year":"2025","journal-title":"Front. Biosci. Landmark"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129675","article-title":"A novel synergistic enzyme-antibiotic therapy with immobilization of mycobacteriophage Lysin B enzyme onto Rif@ UiO-66 nanocomposite for enhanced inhaled anti-TB therapy; Nanoenzybiotics approach","volume":"262","author":"Eldin","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.123160","article-title":"Engineered extracellular vesicles loaded in boronated cyclodextrin framework for pulmonary delivery","volume":"352","author":"Ren","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib187","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejpb.2020.05.014","article-title":"In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa","volume":"152","author":"Tewes","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib188","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1038\/s41564-024-01807-6","article-title":"Bismuth-based drugs sensitize Pseudomonas aeruginosa to multiple antibiotics by disrupting iron homeostasis","volume":"9","author":"Xia","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105698","article-title":"Intra-tracheal administration increases gallium availability in lung: implications for antibacterial chemotherapy","volume":"170","author":"Mitidieri","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib190","doi-asserted-by":"crossref","first-page":"15254","DOI":"10.1021\/acsnano.3c01942","article-title":"Stimuli-responsive functional micro-\/nanorobots: a review","volume":"17","author":"Zhou","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.03.056_bib191","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj7067","article-title":"Pain-free oral delivery of biologic drugs using intestinal peristalsis\u2013actuated microneedle robots","volume":"10","author":"Gao","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib192","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000366","article-title":"Bioinspired soft microrobots with precise magneto\u2010collective control for microvascular thrombolysis","volume":"32","author":"Xie","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib193","article-title":"Cardiac organoid model inspired micro\u2010robot smart patch to treat myocardial infarction","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib194","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41467-025-56032-4","article-title":"Inhalable biohybrid microrobots: a non-invasive approach for lung treatment","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib195","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwac221","article-title":"Probiotic-based nanoparticles for targeted microbiota modulation and immune restoration in bacterial pneumonia","volume":"10","author":"Fu","year":"2023","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib196","article-title":"Hybrid cell membrane\u2010engineered nanocarrier for triple\u2010action strategy to address Pseudomonas aeruginosa infection","volume":"12","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib197","first-page":"801","article-title":"Spore-inspired inhalation drug delivery system for asthma therapy","volume":"53","author":"Tong","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.056_bib198","first-page":"12","article-title":"Intrinsically bioactive and biomimetic nanoparticle-derived therapies alleviate asthma by regulating multiple pathological cells","volume":"28","author":"Cai","year":"2023","journal-title":"Bioact. Mater."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26001969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26001969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:09:53Z","timestamp":1783922993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26001969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":198,"alternative-id":["S2452199X26001969"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.03.056","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}